{"name":"Primidone","slug":"primidone","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Primaclone","Mysoline","Lepimidin","2-Deoxyphenobarbital","Lepsiral","Liskantin","Milepsin","Mylepsin","Mysedon","Primakton"],"brands":[],"scraped":true,"has_structure":true,"cid":4909,"classes":[],"families":[{"name":"phenethylamine","href":"/substituted/phenethylamine"},{"name":"barbiturate","href":"/substituted/barbiturate"}],"physical":[{"label":"Molecular mass","value":"218.25 g/mol","copyable":false},{"label":"Appearance","value":"Crystals","copyable":false},{"label":"Odor","value":"Odorless","copyable":false},{"label":"Taste","value":"Practically tasteless","copyable":false},{"label":"Melting point","value":"538 to 540 °F (NTP, 1992)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitrogen oxides/.","copyable":false},{"label":"Solubility","value":"less than 1 mg/mL at 66 °F (NTP, 1992)","copyable":false},{"label":"Predicted LogP","value":"0.9","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>12</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"5-ethyl-5-phenyl-1,3-diazinane-4,6-dione","copyable":true},{"label":"SMILES","value":"CCC1(C(=O)NCNC1=O)C2=CC=CC=C2","copyable":true},{"label":"InChI","value":"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)","copyable":true},{"label":"InChIKey","value":"DQMZLTXERSFNPB-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"125-33-7","copyable":true},{"label":"UNII","value":"13AFD7670Q","copyable":true},{"label":"PubChem CID","value":"4909","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"Primidone: 5-18 h,, Phenobarbital: 75-120 h,, PEMA: 16 h, Time–reach steady state:, Primidone: 2-3 days,, Phenobarbital&amp;PEMA 1-4weeks<a href=\"#cite_note-3\"><sup>[3]</sup></a><a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"ip","dose":"332 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"oral","dose":"280 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"ip","dose":"240 mg/kg"},{"kind":"LD50","organism":"Rat","route":"oral","dose":"1500 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Sodium primidone","name":"sodium","slug":"sodium_primidone","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N03","description":"Antiepileptics"},{"code":"N03A","description":"Antiepileptics"},{"code":"N03AA","description":"Barbiturates and derivatives"},{"code":"N03AA03","description":""},{"code":"N03AA03","description":"Primidone"}],"mesh":[{"name":"Anticonvulsants","id":"M0001382"},{"name":"GABA Modulators","id":"M0028093"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Primidone and its metabolites, phenobarbital and phenylethylmalonamide (PEMA), are active anticonvulsants. Primidone does not directly interact with GABA-A receptors or chloride channels but phenobarbital does. Primidone alters transmembrane sodium and calcium channel transport, reducing the frequency of nerve firing, which may be responsible for the primidone’s effect on convulsions and essential tremor.","side_effects":{"drug_id":4909,"drug_name":"primidone","url":"https://sideeffects.embl.de/drugs/4909/pt","atc_codes":["N03AA03"],"side_effects":[{"name":"Agranulocytosis","cui":"C0001824"},{"name":"Anaemia","cui":"C0002871"},{"name":"Anaemia megaloblastic","cui":"C0002888"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Ataxia","cui":"C0004134"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Connective tissue disorder","cui":"C0009782"},{"name":"Muscle contracture","cui":"C0009917"},{"name":"Depression","cui":"C0011570"},{"name":"Diplopia","cui":"C0012569"},{"name":"Dizziness","cui":"C0012833"},{"name":"Somnolence","cui":"C2830004"},{"name":"Emotional disorder","cui":"C0233459"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Eruption","cui":"C0302295"},{"name":"Eye disorder","cui":"C0015397"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Gastrointestinal disorder","cui":"C0017178"},{"name":"Headache","cui":"C0018681"},{"name":"Blood disorder","cui":"C0018939"},{"name":"Systemic lupus erythematosus","cui":"C0024141"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervous system disorder","cui":"C0027765"},{"name":"Nystagmus","cui":"C0028738"},{"name":"Psychotic disorder","cui":"C0033975"},{"name":"Vertigo","cui":"C0042571"},{"name":"Vomiting","cui":"C0042963"},{"name":"Apathy","cui":"C0085632"},{"name":"Flat affect","cui":"C0233471"},{"name":"Malnutrition","cui":"C0162429"},{"name":"Skin disorder","cui":"C0037274"},{"name":"Personality change","cui":"C0240735"},{"name":"Aplasia","cui":"C0243065"},{"name":"Suicidal ideation","cui":"C0424000"},{"name":"Visual impairment","cui":"C3665347"},{"name":"Suicidal behaviour","cui":"C1760428"}],"indications":[{"name":"Bone disorder","cui":"C0005940"},{"name":"Epilepsy","cui":"C0014544"},{"name":"Jacksonian seizures","cui":"C0022333"},{"name":"Myoclonus","cui":"C0027066"},{"name":"Tonic-clonic seizures","cui":"C0494475"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"C1","act":null,"refs":[5]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[6]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Primidone"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/4909"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q420383"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00794"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL856"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A8412"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=125-33-7"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014932"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07371"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID7023510"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Primidone"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/13AFD7670Q"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4909/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 4909, Primidone. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/4909>https://pubchem.ncbi.nlm.nih.gov/compound/4909</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Primidone. UNII: 13AFD7670Q. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/13AFD7670Q>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/13AFD7670Q</a>","Primidone (Mysoline). Pharmacology Guide for Brain Injury Treatment. 2003–2005. <a href='http://www.birf.info/home/bi-tools/qlinks_anticon.html'>http://www.birf.info/home/bi-tools/qlinks_anticon.html</a>","Therapeutic Drug Levels. YNHH Laboratory Manual - Reference Documents. 1998. <a href='http://info.med.yale.edu/labmed/clinical/labman/D011.html'>http://info.med.yale.edu/labmed/clinical/labman/D011.html</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Primidone SERB 50mg Tablets - Summary of Product Characteristics (SmPC). (emc). 18 August 2014. <a href='https://www.medicines.org.uk/emc/product/2941/smpc'>https://www.medicines.org.uk/emc/product/2941/smpc</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:01:45","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 18:01:41","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 18:01:41","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:01:42","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:01:41","note":"hmdb.ca refused automated access to HMDB0014932"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:01:43","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:01:41","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:01:41","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 18:01:41","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:01:41","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:01:41","note":null}],"description":"Primidone is a  substance."}